A detailed history of Alliancebernstein L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 123,050 shares of HRMY stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,050
Previous 155,510 20.87%
Holding current value
$4.27 Million
Previous $4.69 Million 4.78%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $973,800 - $1.3 Million
-32,460 Reduced 20.87%
123,050 $4.92 Million
Q1 2024

May 14, 2024

SELL
$29.93 - $35.06 $317,168 - $371,530
-10,597 Reduced 6.38%
155,510 $5.22 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $380,678 - $669,756
19,827 Added 13.55%
166,107 $5.37 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $2.04 Million - $2.49 Million
63,910 Added 77.59%
146,280 $4.79 Million
Q2 2023

Aug 15, 2023

SELL
$30.5 - $37.4 $581,818 - $713,442
-19,076 Reduced 18.8%
82,370 $2.9 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $1.41 Million - $2.46 Million
45,623 Added 81.73%
101,446 $3.31 Million
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $1.09 Million - $1.46 Million
23,977 Added 75.29%
55,823 $3.08 Million
Q3 2022

Nov 15, 2022

SELL
$42.06 - $55.45 $140,396 - $185,092
-3,338 Reduced 9.49%
31,846 $1.41 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $52.15 $119,033 - $185,080
3,549 Added 11.22%
35,184 $1.72 Million
Q1 2022

May 13, 2022

SELL
$33.14 - $51.13 $9,908 - $15,287
-299 Reduced 0.94%
31,635 $1.54 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $771,593 - $993,858
22,634 Added 243.38%
31,934 $1.36 Million
Q3 2021

Nov 10, 2021

SELL
$25.68 - $38.61 $138,672 - $208,494
-5,400 Reduced 36.73%
9,300 $356,000
Q2 2021

Jul 30, 2021

BUY
$25.96 - $33.44 $381,612 - $491,567
14,700 New
14,700 $415,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.